Trial · NCT00051545
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to relapse, relapse being defined as the first recurrence of HCC (intra- or extrahepatic). | ||
| Secondary | Survival | ||
| Secondary | Time to distant recurrence of HCC | ||
| Secondary | Time to second primary HCC | ||
| Secondary | Time to development of metastases | ||
| Secondary | Tumour measurements | ||
| Secondary | Tumour marker (alpha-fetoprotein AFP) | ||
| Secondary | Quality of life | ||
| Secondary | Length of hospital stay | ||
| Secondary | Adverse events | ||
| Secondary | Laboratory safety examinations | ||
| Secondary | Dose of Seocalcitol |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00051545/registered